|
ZNF281 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.05279999995656E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.50679999483461E-08 |
| Normal-vs-Stage2 |
3.419700E-03 |
| Normal-vs-Stage3 |
6.416800E-01 |
| Normal-vs-Stage4 |
4.849400E-01 |
| Stage1-vs-Stage2 |
3.277000E-01 |
| Stage1-vs-Stage3 |
1.804080E-02 |
| Stage1-vs-Stage4 |
5.851700E-02 |
| Stage2-vs-Stage3 |
1.382170E-01 |
| Stage2-vs-Stage4 |
3.653600E-01 |
| Stage3-vs-Stage4 |
7.652200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.35450000005033E-06 |
| Normal-vs-AfricanAmerican |
2.23229999999353E-05 |
| Normal-vs-Asian |
4.183200E-01 |
| Caucasian-vs-AfricanAmerican |
6.826200E-01 |
| Caucasian-vs-Asian |
6.272000E-01 |
| AfricanAmerican-vs-Asian |
4.828800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.15870000039209E-07 |
| Normal-vs-Female |
1.406990E-01 |
| Male-vs-Female |
4.550500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.175960E-03 |
| Normal-vs-Extreme_Weight |
1.75429670790095E-11 |
| Normal-vs-Obese |
3.069600E-02 |
| Normal-vs-Extreme_Obese |
3.50380000000428E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.456300E-02 |
| Normal_Weight-vs-Obese |
3.789400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.133750E-01 |
| Extreme_Weight-vs-Obese |
1.937040E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.221800E-01 |
| Obese-vs-Extreme_Obese |
1.638080E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.944400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.49820000000267E-05 |
| Normal-vs-Age(61-80Yrs) |
3.40010000154933E-08 |
| Normal-vs-Age(81-100Yrs) |
7.70870000055268E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.088800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.411700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.627530E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.473900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.915600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.168000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.58699786224315E-11 |
| Normal-VS-Type2 PRCC |
1.537490E-03 |
| Normal-VS-KIRP CIMP |
9.761600E-02 |
| Normal-VS-Unclassified PRCC |
4.250200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.345800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.741300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.250170E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.122300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.307800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.107900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.72100000034514E-07 |
| Normal-vs-N1 |
2.932000E-01 |
| Normal-vs-N2 |
5.060200E-01 |
| N0-vs-N1 |
1.679440E-03 |
| N0-vs-N2 |
3.259800E-01 |
| N1-vs-N2 |
3.464000E-01 |
|
|
